SerbinCreative

(805) 963-0439 | Toll-Free (800) 876-6425

www.serbincreative.com LA / NY / UK

Kryski Biomedia

ADA-SCID Mechanism of Disease 

Prev Next
Previous

CRYSVITA Mechanism of Action

medical illustration of This is a MOD graphic of ADA-SCID (Adenosine deaminase severe combined immune deficiency), an ultra-rare inherited genetic disorder. It is caused by a deficiency in the adenosine deaminase (ADA) enzyme and is often fatal if untreated. ADA deficiency increases the risk of severe and recurring infections by inducing apoptosis in B, T, and NK lymphocytes through toxic buildups of deoxyadenosine. Client: Leadiant Biosciences
Next medical illustration of This series of panels shows the comparison of the breakdown of cellular waste in healthy cells vs cells with ceroid lipofuscinosis type 2 (CLN2). The bottom panel shows the MOA of the NAV technology, which uses an AAV to transport functional TPP1 into the CLN2 patient.

CLN2 Mechanism of Disease

This is a MOD graphic of ADA-SCID (Adenosine deaminase severe combined immune deficiency), an ultra-rare inherited genetic disorder. It is caused by a deficiency in the adenosine deaminase (ADA) enzyme and is often fatal if untreated. ADA deficiency increases the risk of severe and recurring infections by inducing apoptosis in B, T, and NK lymphocytes through toxic buildups of deoxyadenosine. Client: Leadiant Biosciences

Keywords: Cartoon, Color, Line with Color, Patient Education, Web, Cell biology / Histology, Genetics, Molecular Biology, Mechanism of Action (MOA), Pathology

© Diana Kryski